77 related articles for article (PubMed ID: 3502651)
1. Interleukin 2 (IL 2) and cancer. In vitro response to exogenous R and non-R IL 2 by PHA-activated and non-PHA-activated PBMC from patients with cancer.
Mantovani G; Coiana A; Massidda A; Proto E; Floris C; Macciò A; Pusceddu G; Del Giacco GS
J Exp Pathol; 1987; 3(4):539-47. PubMed ID: 3502651
[No Abstract] [Full Text] [Related]
2. Interleukin 2 (IL 2) relationships with the cancer-related immunodeficiency: in vitro response to exogenous IL 2 by PHA-activated and non PHA-activated peripheral blood mononuclear cells from cancer patients.
Mantovani G; Coiana A; Massidda A; Proto E; Floris C; Macciò A; Pusceddu G; Del Giacco GS
Diagn Clin Immunol; 1987; 5(2):104-11. PubMed ID: 3497733
[TBL] [Abstract][Full Text] [Related]
3. Role of interleukin-2 (IL-2) in cancer-related immune deficiency: in vitro response to IL-2, production of IL-2, and IL-2 receptor expression in patients with advanced cancer.
Mantovani G; Coiana A; Massidda A; Proto E; Floris C; Macciò A; Pusceddu G; Del Giacco GS
Cancer Detect Prev; 1988; 12(1-6):149-59. PubMed ID: 3263194
[TBL] [Abstract][Full Text] [Related]
4. Impaired T cell proliferation in acute dengue infection.
Mathew A; Kurane I; Green S; Vaughn DW; Kalayanarooj S; Suntayakorn S; Ennis FA; Rothman AL
J Immunol; 1999 May; 162(9):5609-15. PubMed ID: 10228044
[TBL] [Abstract][Full Text] [Related]
5. Effect of phorbol myristate acetate (PMA) and ionophore A23187 on interleukin-2 levels and proliferation of activated T lymphocytes from patients with lepromatous leprosy.
Alfaro-Bustamante F; Ramirez-Flores G; Gonzalez-Mendoza A; Islas-Rodriguez A; Fafutis-Morris M
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):73-9. PubMed ID: 9207756
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the inhibitory effects of budesonide on the mitogen-induced or the allergen-induced activation of blood mononuclear cells isolated from asthmatic patients.
Oddera S; Silvestri M; Sacco O; Lantero S; Morelli MC; Rossi GA
Ann Allergy Asthma Immunol; 1995 Jul; 75(1):33-40. PubMed ID: 7621058
[TBL] [Abstract][Full Text] [Related]
7. Antitumor properties of mononuclear cells activated by combined treatment with oxidizing mitogens and interleukin-2: basic and clinical studies.
Novogrodsky A; Stenzel KH
Bull N Y Acad Med; 1989 Jan; 65(1):120-7. PubMed ID: 2605394
[No Abstract] [Full Text] [Related]
8. In vitro effect of indomethacin on mitogen-induced lymphoproliferative response in lung cancer patients.
Stanojević-Bakić N; Vucković-Dekić L; Susnjar S; Spuzić I
Neoplasma; 1992; 39(2):129-32. PubMed ID: 1326720
[TBL] [Abstract][Full Text] [Related]
9. Abnormal indomethacin-sensitive suppression in peripheral blood mononuclear cells of cancer patients restricts augmentation by interleukin-2.
Braun DP; Harris JE
J Biol Response Mod; 1984 Oct; 3(5):533-40. PubMed ID: 6239013
[TBL] [Abstract][Full Text] [Related]
10. Type 1 vs. type 2 cytokine secretion in vitro and its regulation by hydrocortisone in humans subjected to 120-day anti-orthostatic bed-rest regime.
Uchakin PN; Tobin BW; Morukov BV; Larina IV; Cubbage ML
J Gravit Physiol; 2002 Dec; 9(2):71-82. PubMed ID: 14638461
[TBL] [Abstract][Full Text] [Related]
11. Increased spontaneous but decreased mitogen-stimulated expression and excretion of interleukin 18 by mononuclear cells in patients with active systemic lupus erythematosus.
Lee HT; Chen WS; Sun KH; Chou CT; Tsai CY
J Rheumatol; 2009 Sep; 36(9):1910-6. PubMed ID: 19605669
[TBL] [Abstract][Full Text] [Related]
12. beta-galactosidase transduced T lymphocytes: a comparison between stimulation by either PHA and IL-2 or a mixed lymphocyte reaction.
Di Ianni M; Casciari C; Ciurnelli R; Fulvi A; Bagnis C; Lucheroni F; Falzetti F; Mannoni P; Martelli MF; Tabilio A
Haematologica; 1996; 81(5):410-7. PubMed ID: 8952153
[TBL] [Abstract][Full Text] [Related]
13. T lymphocytes from alcoholic cirrhotic patients show normal interleukin-2 production but a defective proliferative response to polyclonal mitogens.
Girón-González JA; Alvarez-Mon M; Menéndez-Caro JL; Manzano L; Abreu L; Yebra M; Durántez-Martínez A
Am J Gastroenterol; 1994 May; 89(5):767-73. PubMed ID: 8172154
[TBL] [Abstract][Full Text] [Related]
14. Generation of human lymphokine-activated killer cells following an IL-2 pulse in elderly cancer patients.
Provinciali M; Di Stefano G; Stronati S; Fabris N
Cytokine; 1998 Feb; 10(2):132-9. PubMed ID: 9512903
[TBL] [Abstract][Full Text] [Related]
15. Effect of wheat germ agglutinin on the interleukin pathway of human T lymphocyte activation.
Reed JC; Robb RJ; Greene WC; Nowell PC
J Immunol; 1985 Jan; 134(1):314-23. PubMed ID: 3917278
[TBL] [Abstract][Full Text] [Related]
16. Competition of IL-1 and IL-1ra determines lymphocyte response to delayed stimulation with PHA.
Dabrowski MP; Stankiewicz W; Płusa T; Chciałowski A; Szmigielski S
Mediators Inflamm; 2001 Jun; 10(3):101-7. PubMed ID: 11545246
[TBL] [Abstract][Full Text] [Related]
17. Regulation of IFN-gamma induction in human peripheral blood cells by exogenous and endogenously produced interleukin 2.
Vilcek J; Henriksen-Destefano D; Siegel D; Klion A; Robb RJ; Le J
J Immunol; 1985 Sep; 135(3):1851-6. PubMed ID: 3926889
[TBL] [Abstract][Full Text] [Related]
18. Peripheral blood mononuclear cells from autologous hematopoietic stem cell transplantation recipients produce and respond to IL-12.
Guillaume T; Kubin M; Sekhavat M; Rubinstein DB; Trinchieri G; Symann M
Bone Marrow Transplant; 1996 Oct; 18(4):733-9. PubMed ID: 8899188
[TBL] [Abstract][Full Text] [Related]
19. A phase I study of recombinant human interleukin-4 administered by the intravenous and subcutaneous route in patients with advanced cancer: immunological studies.
Ghosh AK; Smith NK; Prendiville J; Thatcher N; Crowther D; Stern PL
Eur Cytokine Netw; 1993; 4(3):205-11. PubMed ID: 8218945
[TBL] [Abstract][Full Text] [Related]
20. Recovery of IFN-gamma levels in PBMCs from lepromatous leprosy patients through the synergistic actions of the cytokines IL-12 and IL-18.
Lopez Roa RI; Guerrero Velásquez C; Alvarado Navarro A; Montoya Buelna M; Garcia Niebla C; Fafutis Morris M
Int Immunopharmacol; 2008 Dec; 8(13-14):1715-20. PubMed ID: 18708162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
